Reye's syndrome is most frequently seen in children but has also been described in adults. This syndrome is usually associated with ingestion of 5-aminosalicylates (ASA) or infection with influenza A, influenza B, or varicelia virus. A case of Reye's syndrome in a 47 year old, previously healthy woman precipitated by ingestion of ASA and acute hepatitis A virus infection is described. Reye's syndrome was diagnosed on the basis of her clinical course, and the presence ofhepatic microvesicular steatosis and characteristic electron microscopic changes in the hepatocyte mitochondria. The diagnosis of hepatitis A was based on higher aminotransferase values than would be expected in Reye's syndrome alone, viral serology including the presence of hepatitis A IgM and the demonstration ofhepatitis A virus RNA on liver biopsy by in situ hybridisation. Mitochondrial injury has been demonstrated in acute hepatitis A which, in addition to ASA, may have precipitated Reye's syndrome in this patient. The association between hepatitis A and Reye's syndrome has not been reported before. As hepatitis A virus infection is not sought routinely in patients with Reye's syndrome, the frequency of this association is unknown. (Gut 1997; 41: 121-124) Keywords: hepatitis A; Reye's syndrome Reye's syndrome is most commonly seen in children and is usually preceded by an upper respiratory tract viral infection. It is an acute, potentially life threatening illness affecting predominantly the brain and liver. We report a case of Reye's syndrome in a 47 year old adult, which seems to have been precipitated by hepatitis A infection. To our knowledge, this is the first time an association between hepatitis A and Reye's syndrome has been described.
Reye's syndrome is most commonly seen in children and is usually preceded by an upper respiratory tract viral infection. It is an acute, potentially life threatening illness affecting predominantly the brain and liver. We report a case of Reye's syndrome in a 47 year old adult, which seems to have been precipitated by hepatitis A infection. To our knowledge, this is the first time an association between hepatitis A and Reye's syndrome has been described.
Case report A 47 year old female dietitian developed myalgia, rhinitis, and cough. She took acetyl salicylic acid and acetaminophen at the recommended dosage. She subsequently developed nausea and vomiting. Five days after the start of her illness she became stuporous with inappropriate behaviour and was transferred to our institution from her local hospital.
She had been entirely well in the past with previous admission to hospital only for the birth of her four children. Two of her sons suffered from spinal muscular dystrophy. There was no past history of ethanol misuse or liver disease.
On examination, she was afebrile and her blood pressure was 160/90 mm Hg. She was deeply comatose with posturing characterised by pronation and internal rotation of her upper limbs. There was no evidence of papilloedema. Her plantar responses were up, going bilaterally, but there were no other localising neurological signs. She had no stigmata of chronic liver disease and there was no hepatic or splenic enlargement. Preliminary investigation showed the following: white blood cell (WBC) count 64X I09/1, haemoglobin 148 g/l, platelet count 248X 109/1, prothrombin time (PT) international normalised ratio (INR) 2-1, partial thromboplastin time 39-6 seconds, aspartate aminotransferase (AST) >5000 IU/l (normal range 5-45 lUll), alanine aminotransferase (ALT) >5000 IU/l (normal range 1-oxidation cycle, the patient and one of her sons with spinal muscular dystrophy were screened for evidence of defects. W'hile fasting, )halogram showed diffuse serum amino acid and plasma lactate )hasic waves consistent with concentrations were normal. The patient had )pathy. When the patient's a normal total plasma carnitine as well as results became available, she normal free, acyl and free/total carnitine to have fulminant hepatic concentrations. Her son's acyl carnitine to viral hepatitis. The patient concentration was slightly raised at 39 3 jxmol/l to the intensive care unit (normal range 0-36 ,umol/l), but total, free intubated and treated with and free/total carnitine concentrations were and intravenous mannitol. normal. er biopsy after two units of ;ma revealed diffuse microis characteristic of Reye's Discussion The identity of the fat was Reye's syndrome is most commonly seen in 1i Red 0 staining of frozen children but has also been reported in adults.34 ectron microscopy which also This patient fulfilled the diagnostic criteria for aracteristic rarefaction and Reye's syndrome5 and her liver biopsy speciification of mitochondria. men showed characteristic microvesicular steagical findings included a tosis and mitochondrial injury. Her lack of Lnd peripheral lymphocytic, neurological deterioration and mild coaguloeosinophilic inflammatory pathy despite deep coma were considered apoptotic bodies within the unusual for fulminant hepatic failure and more consistent with Reye's syndrome. Infection with HAV was established with positive IgM serology and by showing the presence of HAV RNA in the liver using in situ hybridisation. Her notably increased AST activity was unusual for Reye's syndrome. In seven previously reported cases of Reye's syndrome in adults, the AST activity ranged from 270 to 1500 IU/l.3 The portal and lobular inflammatory cell infiltrate also suggested a second hepatic insult. 6 The pathogenesis of Reye's syndrome is incompletely understood.7 Ultrastructural examination of hepatocytes shows pleomorphic enlarged mitochondria with disrupted cristae, electron lucent matrixes and dense lucent bodies.8 Corkey et al9 described intrahepatic accumulation of short and medium chain acyl coenzyme A (CoA) intermediates which deplete intramitochondrial ATP. Van Coster et al' have shown that although immunologically active enzyme subunits are present in the mitochondrial matrix in normal amounts, there is a non-uniform decrease in mitochondrial enzyme activities. They suggested that a lack of ATP impairs the assembly of enzymes in the intramitochondrial matrix. The resulting compromise in metabolic pathways may be responsible for producing Reye's syndrome. Moreover ' An immune mechanism for its role in precipitating Reye's syndrome is unlikely, however, in view of the antigen diversity between the various viruses which precede Reye's syndrome and because the primary site of damage is within the mitochondria. Finally, we did not find evidence to suggest a defect in the mitochondrial n-oxidation pathway in the patient or her son with spinal muscular dystrophy; however, such an association is worthy of future study in patients with Reye's syndrome. It is possible that hepatitis A and Reye's syndrome were coincidental findings in this patient, but the simultaneous presentation of two unrelated acute liver diseases seems unlikely. As HAV infection is not routinely sought in patients with Reye's syndrome, the frequency of this association is unknown.
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